Where will the big winners in the medical industry, Google, Johnson & Johnson and Abbott be bet?
How Abbott, Google Alphabet, Johnson & Johnson, and Veeva Systems will seize the "first move."
The medical industry is experiencing rapid development and change. However, which types of companies will gain the most in the transition and become the leading winners? The three authors of The Motley Fool analyzed the medical investments of Abbott, Google's parent company Alphabet, Johnson & Johnson, and global software application services giant Veeva Systems, and concluded that these large companies are moving into the following areas. Boldly bet, they are considered to represent the future of medical care.
Exploring the mystery of youth
The Motley Fool, author of George Budwell, commented on the collaboration between Abbott and Google Alphabet: assuming that anything can be called a “moon landing†project, Abbott and Google parent company Alphabet are working together on aging disease research. . As early as 2014, Abbott signed a contract with Calico, a life sciences subsidiary of Alphabet, which has $1.5 billion in research and development funds, and became a Google pharmaceutical advisor. The essence of this unique collaboration is that a pharmaceutical giant and a technology giant have joined forces to spend huge sums of money on diseases that are highly associated with age, such as cancer and Alzheimer's disease.
In addition to announcing that mice will be tested in terms of molecular and genetic aspects of longevity, the two companies have not disclosed much information about cooperation. But Abbott has now invested more than $5 million in this high-risk study – a very strong signal: Abbott and Google want to play really, they want to make new therapies that can change the rules of the game, grab the medicine New business market. Even if the probability of failure of this move is quite high, it will not hesitate.
Mouse test of Calico, a life science company owned by Google's parent company (Source: Vice)
Due to the lack of clinical practice, Abbott and Alphabet's anti-aging collaborative research is still in the concept stage. But perhaps one day, when they truly realize the ambition to understand the mechanism of human aging from the molecular level, the conclusion of this "impossible task" will become the guiding ideology of a new generation of medicine.
Laparoscopic Grasper,Dissecting Forceps,Grasping Forceps,Laparoscopy Lung Grasper
ZHEJIANG SHENDASIAO MEDICAL INSTRUMENT CO.,LTD. , https://www.sdsmedtools.com